Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that Dr. Neal Walker, CEO, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference. The virtual presentation will be accessible on-demand starting September 12, 2022, at 7:00 a.m. ET. Management will be available for virtual 1x1 meetings throughout the day. A webcast of the presentation will be available on Aclaris' website for at least 30 days. Aclaris focuses on developing innovative drug candidates for patients with immuno-inflammatory diseases.

WAYNE, Pa., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, CEO of Aclaris, will virtually present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference, which will be available on-demand beginning on Monday, September 12, 2022 at 7:00 a.m. ET. Management will be available September 12th throughout the day for virtual 1x1 meetings.

A webcast of the presentation may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

FAQ

When will Dr. Neal Walker present for Aclaris Therapeutics at the H.C. Wainwright conference?

Dr. Neal Walker will present on September 12, 2022, beginning at 7:00 a.m. ET.

How can I access the Aclaris Therapeutics presentation from the H.C. Wainwright conference?

The presentation will be available on-demand through the 'Events' page on Aclaris' website.

Will there be opportunities for meetings with Aclaris management during the conference?

Yes, Aclaris management will be available for virtual 1x1 meetings throughout September 12, 2022.

What is the focus of Aclaris Therapeutics' drug development?

Aclaris develops novel drug candidates targeting immuno-inflammatory diseases.

How long will the webcast of the Aclaris presentation be available?

The webcast will be archived for at least 30 days on Aclaris' website.